Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours Meeting Abstract
| Authors: | Besse, B.; Drilon, A. E.; Cho, B. C.; Camidge, D. R.; Neal, J.; Lin, C. C.; Liu, S. V.; Nagasaka, M.; Kao, S. C. H.; Felip, E.; Van Der Wekken, A. J.; Lin, C. C.; Bauman, J. R.; Gadgeel, S.; Samant, M.; Shen, J.; Sun, Y.; Zhu, V. W.; Upadhyay, V. A.; Lin, J. J. |
| Abstract Title: | Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S804 |
| End Page: | S805 |
| Language: | English |
| ACCESSION: | WOS:001326612901559 |
| DOI: | 10.1016/j.annonc.2024.08.1313 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1256MO -- Source: Wos |
